Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) FCF Margin (2016 - 2025)

Sanara MedTech's FCF Margin history spans 15 years, with the latest figure at 14.02% for Q4 2025.

  • For Q4 2025, FCF Margin rose 1075.0% year-over-year to 14.02%; the TTM value through Dec 2025 reached 2.1%, up 236.0%, while the annual FY2025 figure was 2.1%, 236.0% up from the prior year.
  • FCF Margin reached 14.02% in Q4 2025 per SMTI's latest filing, up from 4.24% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 14.02% in Q4 2025 to a low of 27.62% in Q1 2022.
  • Average FCF Margin over 5 years is 7.99%, with a median of 8.13% recorded in 2024.
  • Peak YoY movement for FCF Margin: tumbled -819bps in 2021, then skyrocketed 2282bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 27.38% in 2021, then skyrocketed by 83bps to 4.56% in 2022, then decreased by -12bps to 5.1% in 2023, then soared by 164bps to 3.27% in 2024, then surged by 329bps to 14.02% in 2025.
  • Per Business Quant, the three most recent readings for SMTI's FCF Margin are 14.02% (Q4 2025), 4.24% (Q3 2025), and 3.49% (Q2 2025).